RT Journal Article
SR Electronic
T1 Diet, pace of biological aging, and risk of dementia in the Framingham Heart Study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.05.24.23290474
DO 10.1101/2023.05.24.23290474
A1 Thomas, Aline
A1 Ryan, Calen P
A1 Caspi, Avshalom
A1 Moffitt, Terrie E.
A1 Sugden, Karen
A1 Zhou, Jiayi
A1 Belsky, Daniel W.
A1 Gu, Yian
YR 2023
UL http://medrxiv.org/content/early/2023/05/29/2023.05.24.23290474.abstract
AB INTRODUCTION We tested the hypothesis that healthy diet protects against dementia because it slows the pace of biological aging.METHODS We analyzed Framingham Offspring Cohort data (≥60y). We measured healthy diet using the Dietary Guideline for Americans (DGA, 3 visits 1991-2008), pace of aging using the DunedinPACE epigenetic clock (2005-2008), and incident dementia and mortality using records (compiled 2005-2018).RESULTS Of n=1,525 included participants (mean age 69.7, 54% female), n=129 developed dementia and n=432 died over follow-up. Greater DGA adherence was associated with slower DunedinPACE and reduced risks for dementia and mortality. Slower DunedinPACE was associated with reduced risks for dementia and mortality. Slower DunedinPACE accounted for 15% of the DGA association with dementia and 39% of the DGA association with mortality.DISCUSSION Findings suggest that slower pace of aging mediates part of the relationship of healthy diet with reduced dementia risk. Monitoring pace of aging may inform dementia prevention.Competing Interest StatementAvshalom Caspi, Terrie E. Moffitt, Karen Sugden, and Daniel W. Belsky are listed as inventors of DunedinPACE, a Duke University and University of Otago invention licensed to TruDiagnostic Inc. Aline Thomas, Calen P Ryan, Jiayi Zhou, and Yian Gu declare no conflicts of interest.Funding StatementThis work received support from the National Institute on Aging grants R01AG061378, R01AG073402, R01AG059013, and R01AG061008. Avshalom Caspi, Terrie E. Moffitt, and Karen Sugden received support from National Institute on Aging grants R01AG073207 and R01AG049789. Daniel W. Belsky received support as a fellow of the Canadian Institute for Advanced Research CBD Network. The funders had no role in the study design, data collection, data analysis, data interpretation, or writing of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study used only openly available human data from the Framingham Offspring Study obtained from dbGaP (phs000007.v33.p14 and phs000724.v10.p14).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript. https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000007.v33.p14 https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000724.v10.p14